Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)

SGX:T14 Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 20, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,805	4,118	3,547	4,133	2,267	1,752
Market Cap Growth	-2.11%	16.09%	-14.17%	82.26%	29.44%	7.24%
Enterprise Value	3,771	3,891	3,145	3,715	1,941	1,524
Last Close Price	2.87	2.55	1.32	1.25	0.90	0.84
PE Ratio	22.32	22.42	21.17	25.32	16.92	14.50
PS Ratio	2.94	2.69	2.21	2.82	1.70	1.30
PB Ratio	3.66	3.33	2.78	2.99	1.88	1.64
P/TBV Ratio	3.90	3.56	2.96	3.16	2.00	1.74
P/FCF Ratio	22.75	40.40	32.05	28.00	23.22	31.28
P/OCF Ratio	20.09	32.13	26.94	22.84	16.68	18.30
EV/Sales Ratio	2.54	2.54	1.96	2.53	1.45	1.13
EV/EBITDA Ratio	22.06	22.63	20.58	24.96	14.51	12.62
EV/EBIT Ratio	25.67	26.15	24.10	29.82	17.40	14.94
EV/FCF Ratio	19.87	38.17	28.42	25.17	19.88	27.22
Debt / Equity Ratio	0.20	0.05	0.04	0.01	0.01	0.01
Debt / EBITDA Ratio	1.38	0.37	0.34	0.06	0.06	0.07
Debt / FCF Ratio	1.24	0.62	0.47	0.06	0.09	0.15
Asset Turnover	0.76	0.81	0.86	0.80	0.82	0.94
Inventory Turnover	2.60	3.09	3.38	2.76	2.61	2.79
Quick Ratio	1.05	1.51	1.71	1.81	1.85	1.54
Current Ratio	1.70	2.03	2.17	2.64	2.59	2.38
Return on Equity (ROE)	14.18%	14.68%	13.37%	12.63%	11.85%	12.01%
Return on Assets (ROA)	4.69%	4.90%	4.37%	4.23%	4.27%	4.42%
Return on Capital (ROIC)	6.63%	7.24%	6.27%	5.85%	5.96%	6.07%
Return on Capital Employed (ROCE)	11.76%	11.42%	9.84%	8.85%	9.00%	9.29%
Earnings Yield	4.48%	4.46%	4.72%	3.95%	5.91%	6.90%
FCF Yield	4.99%	2.48%	3.12%	3.57%	4.31%	3.20%
Dividend Yield	9.95%	9.33%	16.53%	8.47%	6.77%	6.93%
Payout Ratio	106.14%	88.91%	44.96%	30.17%	35.15%	27.71%
Buyback Yield / Dilution	0.51%	0.71%	-0.94%	0.04%	0.37%	-0.37%
Total Shareholder Return	10.45%	10.04%	15.59%	8.50%	7.14%	6.56%

Source: S&P Capital IQ. Standard template. Financial Sources.